AGAE vs BBGI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AGAE exhibits severe financial distress, as evidenced by a Piotroski F-Score of 1/9, indicating extreme operational weakness and deteriorating fundamentals. The company reports negative profitability across all key margins and returns, with a -280% profit margin and -39.54% ROE, signaling deep operational inefficiencies. Despite a low Price/Book of 0.21, the absence of a Graham Number and intrinsic value estimate, combined with negative earnings and declining revenue, undermines any potential value proposition. The stock's 5-year decline of 89.5% and lack of analyst coverage further reflect market skepticism. With no dividend and weak insider sentiment, the overall outlook remains highly unfavorable.
The Advanced Deterministic Scorecard reveals severe financial distress with a Piotroski F-Score of just 1/9, indicating very weak financial health. Despite deeply depressed valuation multiples—Price/Book of 0.07 and Price/Sales of 0.05—the company faces negative profitability, declining revenues, high leverage, and inconsistent earnings. Negative insider sentiment, with $2.34M in recent insider sales and no buys, reinforces concerns. While short-term price momentum is positive, fundamental deterioration and lack of analyst coverage suggest high risk.
Compare Another Pair
Related Comparisons
AGAE vs BBGI: Head-to-Head Comparison
This page compares Allied Gaming & Entertainment Inc. (AGAE) and Beasley Broadcast Group, Inc. (BBGI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.